Sat.Jul 31, 2021 - Fri.Aug 06, 2021

article thumbnail

Around 250 digital health apps are launching every day, says IQVIA

pharmaphorum

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is currently “middling” it is on the rise, according to a report from IQVIA. The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s acc

145
145
article thumbnail

Artificial intelligence stands to ‘revolutionize’ research: Bioclinica

Outsourcing Pharma

A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it could SOMETHING.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

U.S. ranks last among 10 other countries in new study on healthcare systems

Fierce Healthcare

U.S. ranks last among 10 other countries in new study on healthcare systems. agliadkovskaya. Wed, 08/04/2021 - 10:27.

145
145
article thumbnail

Extending the Patient Lifecycle in Your Pharmacy   

PDS Blog

As an independent pharmacy, your goal is to become a healthcare destination in your community. That means going far beyond dispensing. It means attracting patients that will stay with your pharmacy for the long-term. And don’t forget that a great number of referrals can come from physicians and other members of the community. Being involved […].

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

SMA Awareness Month: How pharma and digital solutions can improve patient care

pharmaphorum

Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide , impacting their ability to walk, eat, and breathe. SMA Type 1 represents an estimated 50% of all cases, for which life expectancy is less than 18 months without treatment. .

article thumbnail

Pharmaceutical industry must fix broken supply chain: Phlow

Outsourcing Pharma

A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.

131
131

More Trending

article thumbnail

Learn all about our private digital ad exchange, EHSx

Pharma Marketing Network

EHSx can connect your brand with your target audiences on over 4,000 quality whitelist healthcare publishers, and 10,000 pharma-safe, non-endemic properties. Download our EHSX one-pager to learn more! Name *. First. Last. Email *. Title Company Hidden Lead Source * Web Active Prospecting Sales Ad-Label Advertising - Offline Advertising - Online Advertising - Online - FocalPoint Advertising - Online - Mobile Advertising - Online - TrendMD Conference/Trade Show Date Connected on LinkedIn Domains D

article thumbnail

Evaluating methods targeting Protein-Protein Interactions

pharmaphorum

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. . The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting the conventional methods. Targeting PPIs offers another potential therapeutic target for diseases with complex biological profiles.

article thumbnail

Psychedelics research institute launches in Australia

Outsourcing Pharma

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

130
130
article thumbnail

Ascension Michigan to pay nearly $3 million in latest settlement to resolve fraud claims

Fierce Healthcare

Ascension Michigan to pay nearly $3 million in latest settlement to resolve fraud claims. agliadkovskaya. Thu, 08/05/2021 - 13:30.

112
112
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Drugs That Cause Hypercalcemia

Med Ed 101

Excess calcium levels can be life-threatening if they become severely elevated (>14 mg/dL), causing symptoms such as polyuria and polydipsia due to nephrogenic diabetes insipidus, nephrolithiasis, bone pain, nausea, vomiting, anorexia, confusion, rare cardiac arrhythmias, and coma. Calcium homeostasis in the body is dependent upon parathyroid hormone (PTH), vitamin D, calcitonin (to a lesser extent), […].

40
article thumbnail

Fresenius launches VR-based training for home dialysis patients

pharmaphorum

Fresenius has launched a virtual reality based training programme for people undergoing home dialysis in Germany, its home market, ahead of a rollout in other countries later this year. The VR system – called stay•safe MyTraining VR – is designed for use in patients undergoing peritoneal dialysis, which uses the peritoneum in a person’s abdomen as the membrane through which fluid and dissolved substances are exchanged with the blood.

111
111
article thumbnail

mRNA and beyond: Opportunities for US biologics

Outsourcing Pharma

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Vaccines 111
article thumbnail

UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours

Pharma Times

Sativex is a complex botanical formulation that contains the principal cannabinoids THC and CBD

63
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Tapering Clonidine – Case Study

Med Ed 101

In this article, I wanted to share information on tapering clonidine. This drug can cause serious rebound hypertension when abruptly discontinued and patients may not understand or realize that this risk exists. Here’s a case scenario that demonstrates tapering clonidine. JS is a 52-year-old female who has a history of resistant hypertension. She was doing […].

40
article thumbnail

Moderna COVID-19 jab sales rocket to $4.2 billion in second quarter

pharmaphorum

Moderna made a massive $4.2 billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around $6 billion from 302 million shots. The tally makes the SpikeVax (mRNA-1273) vaccine the second biggest seller behind Pfizer/BioNTech’s Comirnaty, which pulled in $7.8 billion in the second quarter and $11.3 billion since the start of the year.

Vaccines 105
article thumbnail

Treg cell therapy showing promise in ALS trials: Coya Therapeutics

Outsourcing Pharma

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

119
119
article thumbnail

Finalists announced for CROY 2021

Pharma Times

The finalists have been confirmed for the 2021 Clinical Researcher of the Year – The Americas competition.

49
article thumbnail

COVID-19: The WTF Edition

The Infectious Pharmacist

Photo by Jeff Stapleton on Pexels.com. I feel a bit like Michael Corleone in Godfather Part 3 (yes, it’s the worst of the three, but it’s good for this line): Just when I thought I was out they pull me back in! Unfortunately the only messages about masks, vaccines, and COVID-19 that we’re hearing are: Just when you thought it was safe to go back in the water.

article thumbnail

Predicting and improving clinical trial enrolment: A problem for psychiatry

pharmaphorum

Patient enrollment is a common issue across many therapeutic areas in clinical research. Psychiatric disorders in particular represent a trial area with significantly high drop-out rates and poor patient recruitment. The reasons behind this problem, however, are rarely studied or understood. Despite this, new strategies devised over the last five years are beginning to reverse the trend, and both reduce stigma and increase awareness to funnel new patients into these important trials. .

Hospitals 105
article thumbnail

Arcturus Therapeutics lines up Phase 1/2/3 trial for next-generation mRNA COVID-19 vaccine

Outsourcing Pharma

Arcturus Therapeutics and its Vietnam partner Vinbiocare will take ARCT-154, a next-generation Arcturus vaccine targeting SARS-CoV-2 variants of concern, into a Phase 1/2/3 trial. The companies will also establish a vaccine manufacturing centre in Vietnam.

Vaccines 105
article thumbnail

Gov’t launches study on COVID-19 vaccine dose interval for pregnant women

Pharma Times

The study will be the largest clinical trial of its kind in the UK, involving over 600 pregnant women

article thumbnail

Novartis cleared to restart trials of new Zolgensma delivery route

pharmaphorum

The FDA has relaxed a clinical hold on clinical trials of Novartis’ intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway. Zolgensma (onasemnogene abeparvovec) is already approved as an intravenous treatment in babies and very young children for the rare muscle-wasting disease, but the new OAV-101 IT version is designed to unlock use of the drug in older SMA patients.

FDA 105
article thumbnail

Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases

pharmaphorum

Ipsen’s new chief executive David Loew pledged to ramp up spending on the company’s pipeline when he took the helm last year, and a flurry of licensing deals in the last few weeks shows that push is starting to gather momentum. The French company – which focusing on cancer, neuroscience and rare diseases – has just snapped up two programmes from US biotech Exicure that span the latter two areas, targeted at rare neurodegenerative disorders Huntington’s disease and Angelman synd

105
105
article thumbnail

Lilly has a bad hair day as Pfizer rival hits the mark in alopecia

pharmaphorum

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial. In the phase 2b/3 ALLEGRO trial, JAK inhibitor ritlecitinib hit its primary objective of improving the area of scalp covered by hair in people with this autoimmune form of hair loss, giving Pfizer a positive readout in the first of two trials that will form the basis of regulatory filings for the drug.

Labelling 107
article thumbnail

Why automated metadata management is important for simplifying the clinical trials process

pharmaphorum

The need for automated metadata management software has never been greater. The number of global clinical trials being run is increasing every year. And, they are becoming increasingly complex to manage. There’s a vast amount of data that needs to be collected and analyzed. There are more regulations in place than ever before and industry standards are constantly being updated.

article thumbnail

Failed trial nixes another FDA approval, this time for BMS’ Istodax

pharmaphorum

Bristol-Myers Squibb’s HDAC inhibitor Istodax has been on the US market for a decade as a treatment for peripheral T-cell lymphoma (PTCL), but will now be withdrawn from sale after a failed phase 3 trial. Istodax (romidepsin) – originally developed by Celgene – is the latest in a string of cancer drugs originally given accelerated approval based on mid-stage data to be withdrawn because a follow-up confirmatory trial missed the mark.

FDA 98
article thumbnail

Measuring Advocacy of Digital KOLs

pharmaphorum

Identifying the most important & active digital experts in your space is just the first step of the engagement planning cycle. Because even within a therapy area, digital KOLs (DOLs) have very different online characteristics – those who tend to initiate online conversations, those that tend to create new content, those that tend to propagate existing data, etc., and by engaging with those experts in a way that is aligned with their unique characteristics and personal positioning, you can po

98
article thumbnail

Report: expect the future of US pharma market to be ‘exciting’

Outsourcing Pharma

An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.

105
105
article thumbnail

Understanding Adherence: 5 Questions Patients Want to Be Asked

pharmaphorum

Healthcare professionals and individuals with chronic health conditions understand that various factors can impact the level of adherence to a treatment plan, from lifestyle to side effects. Additionally, it’s clear that HCP relationships can affect a patient’s health journey, which may also impact adherence. Health Union’s white paper, Beyond the Treatment, Making the HCP-Patient Relationship Work: A Study Uncovering the Patient Perspective , explores those relationships in detail.

article thumbnail

AstraZeneca lupus treatment Saphnelo obtains FDA approval

Outsourcing Pharma

The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.

FDA 98
article thumbnail

Spotlight on single-use systems: 3 trends driving demand

Outsourcing Pharma

Adoption of single-use technologies has grown exponentially over the last decade: but what will drive the tech forward in the coming years?

98
article thumbnail

Sanofi swoops on partner Translate, buying the mRNA firm for $3.2bn

pharmaphorum

Sanofi has been forging ever-closer ties with its mRNA partner Translate Bio since the two started working together in 2018, and has now gone all in, offering $3.2 billion to buy the company outright. The $38-per-share deal – a 56% premium to Translate’s recent share price before an after-hours surge in the stock on rumours of the deal yesterday – has already been cleared by the boards of both companies and is due to close in the third quarter.

article thumbnail

How to balance the patient voice atop the shifting plates of HTA

pharmaphorum

The tectonic plates of healthcare technology assessment (HTA) have shifted – but where does the patient voice fit within this new evaluation paradigm? Recent advances in medical science, from genomics and gene therapies to artificial intelligence (AI), have transformed the healthcare landscape, and triggered a review of NICE’s methods and processes.